TSX:MHCD Holdings Information

TSX:MHCD is an equity ETF with a total of 44 individual holdings. The top holdings are Johnson & Johnson stock at 6.28%, Eli Lilly and Company at 6.02%, AstraZeneca at 5.36%, Cash & Other at 5.25%, and AbbVie at 4.74%.

Total Holdings

Top 10 Percentage

45.94%

Asset Class

Equity

ETF Category

Health Care

Assets

137.07M

PE Ratio

24.34

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	6.28%	28,000
2	LLY	Eli Lilly and Company	6.02%	6,600
3	LON: AZN	AstraZeneca PLC	5.36%	29,000
4	n/a	Cash & Other	5.25%	n/a
5	ABBV	AbbVie Inc.	4.74%	23,000
6	MRK	Merck & Co., Inc.	4.26%	40,000
7	TMO	Thermo Fisher Scientific Inc.	3.88%	8,300
8	TSX: CSH.UN	Chartwell Retirement Residences	3.72%	241,000
9	SYK	Stryker Corporation	3.23%	10,500
10	MCK	McKesson Corporation	3.18%	4,000
11	ISRG	Intuitive Surgical, Inc.	3.17%	7,100
12	VRTX	Vertex Pharmaceuticals Incorporated	2.79%	6,700
13	DHR	Danaher Corporation	2.76%	15,800
14	SWX: NOVN	Novartis AG	2.75%	19,000
15	TSX: EXE	Extendicare Inc.	2.69%	125,000
16	MDT	Medtronic plc	2.61%	33,000
17	ABT	Abbott Laboratories	2.57%	29,000
18	UNH	UnitedHealth Group Incorporated	2.53%	7,000
19	GILD	Gilead Sciences, Inc.	2.43%	19,000
20	BMY	Bristol-Myers Squibb Company	2.31%	39,000
21	SWX: ROP	Roche Holding AG	2.23%	5,600
22	NTRA	Natera, Inc.	2.21%	11,000
23	PFE	Pfizer Inc.	2.11%	81,000
24	EPA: SAN	Sanofi	2.01%	22,000
25	AMGN	Amgen Inc.	1.79%	5,300

Showing 25 of 44 holdings

Subscribe to see the full list

Activate Now

As of Apr 30, 2026